MA17065

Mycobacterium tuberculosis 16 kDa Monoclonal Antibody (G06I), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 MA17065-Each-of-1 In Stock ₹ 50,507.50

MA17065 - Each of 1

₹ 50,507.50

In Stock

Quantity

1

Base Price: ₹ 50,507.50

GST (18%): ₹ 9,091.35

Total Price: ₹ 59,598.85

Antigen

Mycobacterium tuberculosis 16 kDa

Classification

Monoclonal

Concentration

0.1 mg/mL

Formulation

PBS with 0.1% sodium azide; pH 7.2

Host Species

Mouse

Purification Method

Protein A

Regulatory Status

RUO

Target Species

Bacteria

Product Type

Antibody

Isotype

IgG2a

Applications

ELISA, Western Blot

Clone

G06I

Conjugate

Unconjugated

Gene Alias

m tuberculosis; M. tuberculosis

Immunogen

M. tuberculosis lysate.

Quantity

1 mL

Primary or Secondary

Primary

Content And Storage

4° C

Form

Liquid

Related Products

Img

Thermo Scientific

MA17005

--

Img

Thermo Scientific

MA17029

--

Img

Thermo Scientific

MA17458

--

Img

Thermo Scientific

MA17414

--

Img

Thermo Scientific

MA17416

--

Img

Thermo Scientific

MA17479

--

Img

Thermo Scientific

MA17041

--

Img

Thermo Scientific

MA17039

--

Description

  • MA1-7065 detects the Mycobacterium tuberculosis
  • This antibody recognizes the 16kDa antigen (HspX) of Mycobacterium tuberculosis and M
  • bovis
  • MA1-7065 has been successfully used in ELISA and Western blot procedures
  • The MA1-7065 immunogen is M
  • tuberculosis lysate
  • Tuberculosis is a chronic bacterial infection which remains one of the leading killers of young adults world wide
  • Mycobacterium tuberculosis enters the alveoli by airborne transmission
  • They are engulfed by alveolar macrophages but resist destruction
  • Although the exact mechanism is not known, it is suspected that that Mycrobacterium tuberculosis survives by preventing the fusion of the phagosome and lysosome
  • As the bacterium accumulates it forms a tubercle, spreads to the lymph nodes and becomes a systemic infection
  • Although treatments for tuberculosis do exist, new strains of Mycobacterium tuberculosis that appear to have multiple-drug resistance (MDR) pose a considerable threat to public health.